RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

RioDerm-001 is under clinical development by Rion and currently in Phase II for Diabetic Foot Ulcers.

Breakthrough microchip technology enables multi-disease detection

In a world grappling with a multitude of health threats -; ranging from fast-spreading viruses to chronic diseases and drug-resistant bacteria -; the need for

December 17, 2024

Multi-tasking doctors at home are watching TV and researching pharma ads — on Google and even EMRs, survey finds

Welcome to the latest pharma marketing hot spot — physicians’ living rooms. Doctors are watching TV at home just like everyone else, but not only

August 19, 2023

PerkinElmer Acquires Covaris to Create Global Life-Sciences and Diagnostics Platform

What You Should Know: – PerkinElmer, a leading global analytical services and solutions provider, announced its acquisition of Covaris, a developer of solutions for life

December 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.